08:00 , Nov 12, 2007 |  BC Week In Review  |  Company News

Biosynth AG, Invitrogen sales and marketing update

Biosynth launched BCM MRSA ELF culture medium to detect methicillin-resistant Staphylococcus aureus (MRSA). The medium uses IVGN's Enzyme-Labeled Fluorescence (ELF) Signal Amplification Technology and fluorogenic media, which Biosynth co-developed. Biosynth AG , Staad, Switzerland  ...